Condition: Head and Neck Cancer · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The aim of this study is to develop an adaptive radiation therapy plan for locally advanced head and neck squamous cell carcinoma receiving induction therapy containing immunotherapy and chemotherapy. The therapy plan is based on clinical remission, in order to reduce treatment-related toxic side effects without sacrificing clinical efficacy and improve the quality of life of patients.
This description comes directly from the study's public registry record.
Yang Meng · 13359595417 · YangMeng@pumc.edu.cn
Always discuss trial participation with your own doctor first.
| National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06345287